TROW
56
-2
KIM
58
7
OKE
56
-3
FOX
59
2
NI
60
-2
AN
61
-2
A
44
-3
FTI
64
-15
DHR
66
-2
HOG
39
-4
MMM
57
-4
MTB
71
2
LEN
36
-4
BDX
55
-5
DHI
33
-6
CB
61
3
OI
49
-2
KMI
55
-8
PPG
49
-3
IR
63
3
TROW
56
-2
KIM
58
7
OKE
56
-3
FOX
59
2
NI
60
-2
AN
61
-2
A
44
-3
FTI
64
-15
DHR
66
-2
HOG
39
-4
MMM
57
-4
MTB
71
2
LEN
36
-4
BDX
55
-5
DHI
33
-6
CB
61
3
OI
49
-2
KMI
55
-8
PPG
49
-3
IR
63
3
Financhill
Back

Salesforce, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
59

CRM
Salesforce, Inc.

Last Price:
$259.55
Seasonality Move:
7.92%
Buy
67

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.99
Seasonality Move:
-31.39%
Buy
59
Salesforce, Inc. (CRM) is a Buy

Is Salesforce, Inc. a Buy, Sell or Hold?

  • The current Salesforce, Inc. [CRM] share price is $259.53. The Score for CRM is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $69.98. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CRM Stock Price Chart

What is Salesforce, Inc.'s stock price today?

  • The Salesforce, Inc. share price today is $259.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing slight selling pressure.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $69.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.

CRM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.24 Buy
Relative Strength Index (14 RSI): 65.26 Buy
Chaikin Money Flow: -2126242 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (229.65 - 251.01) Buy
Bollinger Bands (100): (236.44 - 256.94) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.48 Buy
Relative Strength Index (14 RSI): 86.01 Buy
Chaikin Money Flow: 124529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.63 - 42.89) Buy
Bollinger Bands (100): (18.11 - 33.75) Buy

CRM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 241.56 Buy
20-day SMA: 238.03 Buy
50-day SMA: 243.9 Buy
200-day SMA: 259.21 Buy
8-day EMA: 245.95 Buy
20-day EMA: 241.71 Buy
50-day EMA: 243.57 Buy
200-day EMA: 258.75 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.22 Buy
20-day SMA: 36.44 Buy
50-day SMA: 32.1 Buy
200-day SMA: 23.71 Buy
8-day EMA: 41.78 Buy
20-day EMA: 37.11 Buy
50-day EMA: 32.59 Buy
200-day EMA: 27.3 Buy

Salesforce, Inc. Earnings Growth & CRM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.20 per share, an increase this year of $1.83 per share, and an increase next year of $1.74 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.

Salesforce, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):